Literature DB >> 33662015

Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.

Manna Zhang1, Lin Li2, Ma Luo2,3, Binhua Liang2,4.   

Abstract

COVID-19 has greatly affected public health and world economy. In this study, we analyzed 129 full-length genomes of SARS-CoV-2 viruses of a Canadian population during early phase of the pandemic. Phylogenetic analysis revealed three major paths of transmission of SARS-CoV-2 viruses into Canada. Twenty-one substitutions that have frequencies greater than 3% of viral population were identified. Analysis of these substitutions indicated that P1427I (ORF1b), Y1464C (ORF1b), and Q57H (ORF3a) might affect functions of the corresponding SARS-CoV-2 encoded proteins. Additionally, we found the evidence of positive selection on the ORF3a and codon 614 of Spike protein, suggesting the viral components responsible for host entry and activation of inflammation response were targeted by host immune responses. The study showed genomic variation and evolution of SARS-CoV-2 in a Canadian population. These information may help develop preventive strategies and be used for further study of SARS-CoV-2 pathogenesis and therapeutics development.

Entities:  

Year:  2021        PMID: 33662015     DOI: 10.1371/journal.pone.0247799

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection.

Authors:  Antonio Facciuolo; Erin Scruten; Sean Lipsit; Amanda Lang; Zoë Parker Cates; Jocelyne M Lew; Darryl Falzarano; Volker Gerdts; Anthony J Kusalik; Scott Napper
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

Review 2.  Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19.

Authors:  Jiantao Zhang; Amara Ejikemeuwa; Volodymyr Gerzanich; Mohamed Nasr; Qiyi Tang; J Marc Simard; Richard Y Zhao
Journal:  Front Microbiol       Date:  2022-03-09       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.